Our finding underlines the gravity of dysregulated cell-ECM interaction in CCA malignancy and suggests the optimistic prospect in using LAMA3 not only as the diagnosis biomarker for CCA but also as the therapeutic strategy for desmoplastic CCA therapy. Here, LAMA3 is linked to cholangiocarcinoma.